Lipoprotein metabolism in non-insulin-dependent diabetes mellitus

Journal of Nutritional Biochemistry

Volumn 7, Issue 11, 1996, Pages 586-598

  Barakat, Hisham A ^a   Vadlamudi, Satyaprasad ^a   MacLean, Paul ^a   MacDonald, Kenneth ^a   Pories, Walter J ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

atherosclerosis; diabetes; HDL; insulin resistance; LDL; lipoproteins; VLDL

Indexed keywords

LIPOPROTEIN;

ATHEROSCLEROSIS; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

EID: 0030297950     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(96)00117-9     Document Type: Article

References (182)

1. 1 Kannel, W.B. and McGee, D.L. (1979). Diabetes and cardiovascular disease - the Framingham Study. JAMA 241, 2035-2038
2. 2 Garcia, M.J., McNamara, P.M., Gordon, T., and Kannel, W.B. (1974). Morbidity and mortality in diabetes in Framingham population - sixteen year follow-up study. Diabetes 23, 105-111
3. 3 Taylor, K.G., Wright, A.D., Carter, T.J., Valente, A.J., Betts, S.A., and Mathews, K.A. (1981). High density lipoprotein cholesterol and apolipoprotein A-1 levels at diagnosis in patients with noninsulin dependent diabetes. Diabetologia 20, 535-539
4. 4 Lopes-Virella, M.F.L., Stone, P.G., and Colwell, J.A. (1977). Serum high density lipoproteins in diabetic patients. Diabetologia 13, 285-291
5. 5 Howard, B.V., Savage, P.J., Bennion, L.J., and Bennett, P.H. (1978). Lipoprotein composition in diabetes mellitus. Atherosclerosis 30, 153-162
6. 6 Wilson, P.W.F., Kannel, W.B., and Anderson, K.M. (1985). Lipids, glucose intolerance and vascular disease: The Framingham Study. Monogr. Atherosclerosis 13, 1-11
7. 7 Pyorala, K., Laakso, M., and Uusitup, M. (1987). Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab. Rev. 3, 463-524
8. 8 Bierman, E.L. (1992). Atherogenesis in diabetes. Arterioscler. Thromb. 12, 647-656
9. 9 Greenfield, M., Kolterman, O., Olefsky, J., and Reaven, G.M. (1980). Mechanisms of hypertriglyceredemia in diabetic patients with fasting hyperglycemia. Diabetologia 18, 441-446
10. 10 Greenfield, M.S., Doberne, L., Rosenthal, M., Vreman, H.J., and Reaven, G.M. (1982). Lipid metabolism in non insulin dependent diabetes mellitus. Arch. Intern. Med. 142, 1489-1500
11. 11 Nikkila, E.A. and Kekki, M. (1977). Plasma triglyceride transport in diabetes mellitus. Metabolism 22, 1-22
12. 12 Austin, M.A. and Krauss, R.M. (1986). Genetic control of LDL subclasses. Lancet 2, 592-595
13. 13 Austin, M.A., Breslow, J.L., Hennekens, C.H., Buring, J.E., Willet, W.C., and Krauss, R.M. (1988). Low-Density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260, 1917-1921
14. 14 Austin, M.A., Brunzell, J.D., Fitch, W.L., and Krauss, R.M. (1990). Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 10, 520-530
15. 15 Austin, M.A., Kjing, M.C., Vranizan, K.M., and Krauss, R.M. (1990). Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation 82, 495-506
16. 16 Austin, M.A. (1992). Genetic epidemiology of low-density lipoprotein subclass phenotypes. Ann. Intern. Med. 24, 477-481
17. 17 Austin, M.A. and Krauss, R.M. (1995). LDL density and atherosclerosis. JAMA 273, 115-115
18. 18 Teng, B., Sniderman, A., Krauss, R.M., Kwiterovich, P.O., Milne, R.W., and Marcel, Y. (1985). Modulation of apo-B antegenic determinants in human LDL subclasses. J. Biol. Chem. 260, 5067-5072
19. 19 Teng, B., Thompson, G.R., Sniderman, A.D., Forte, T.M., Krauss, R.M., and Kwiterovich, P.O. Jr. (1983). Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA 80, 6662-6666
20. 20 Musliner, T., Giotas, C., and Krauss, R. (1986). Presence of multiple subpopulations of lipoproteins of intermediate density. Arteriosclerosis 6, 79-87
21. 21 Williams, P.T., Krauss, R.M., Vranizan, K.M., and Wood, P.D.S. (1990). Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. Circulation 81, 1293-1304
22. 22 Musliner, T.A., Long, M.D., Forte, T.M., and Krauss, R.M. (1991). Size transformations of intermediate and low density lipoproteins induced by unesterified fatty acids. J. Lipid Res. 32, 903-915
23. 23 Rudel, L.L., Parks, J.S., Johnson, F.L., and Babiak, J. (1986). Low-density lipoprotein in atherosclerosis. J. Lipid Res. 27, 465-474
24. 24 Fisher, W.R. (1983). Heterogeneity of plasma low density lipoproteins: Manifestations of the physiologic phenomenon in man. Metabolism 32, 283-291
25. 25 Patti, L., Swinburn, B., Riccardi, G., Rivellese, A.A., and Howard, B.V. (1991). Alterations in very low density lipoprotein subfractions in normotriglyceridemic non-insulin-dependent diabetics. Atherosclerosis 91, 15-23
26. 26 Winocour, P.H., Durrington, P.N., Bhatnagar, D., Ishola, M., Arrol, S., and Mackness, M. (1992). Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus. Arterioscler. Thromb. 12, 920-928
27. 27 Taskinen, M.R. (1992). Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 41, 12-17
28. 28 Lahdenperae, S., Tilly-Kiesi, M., Vuorinen-Markkola, H., Kuusi, T., and Taskinen, M.R. (1993). Effects of gemfibrozil on low-density lipoprotein particle size, density distribution, and composition in patients with type II diabetes. Diabetes Care 16, 584-592
29. 29 Kahri, J., Vuorinen-Markkola, H., Tilly-Kiesi, M., Lahdenperae, S., and Taskinen, M.R. (1993). Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin-dependent diabetes. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity. Atherosclerosis 102, 79-89
30. 30 Hamsten, A. and Steiner, G. (1994). Non-insulin-dependent diabetes mellitus and atherosclerosis: A lipoprotein perspective. J. Intern. Med. 236, 1-3
31. 31 Syvanne, M., Ahola, M., Lahdenperae, S., Kahri, J., Kuusi, T., Virtanen, K.S., and Taskinen, M.R. (1995). High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J. Lipid Res. 36, 573-582
32. 32 Lahdenperae, S., Sane, T., Vuorinen-Markkola, H., Knudsen, P., and Taskinen, M.R. (1995). LDL particle size in mildly hypertriglyceridemic subjects: No relation to insulin resistance or diabetes. Atherosclerosis 113, 227-236
33. 33 Austin, M.A., Mykkanen, L., Kuusisto, J., Edwards, K.L., Nelson, C., Haffner, S.M., Pyorala, K., and Laakso, M. (1995). Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation 92, 1770-1778
34. 34 Singh, A.T.K., Rainwater, D.L., Haffner, S.M., VandeBerg, J.L., Shetledy, W.R., Moore, P.H., Jr. and Dyer, T.D. (1995). Effect of diabetes on lipoprotein size. Arterio. Thromb. Vasc. Biol. 15, 1805-1811
35. 35 Ginsberg, H.N. (1987). Very low density lipoprotein metabolism in diabetes mellitus. Diabetes/Met. Rev. 3, 571-589.
36. 36 Kissebah, A.H. (1987). Low density lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Diabetes/Met. Rev. 3, 619-651
37. 37 Chen, Y-D.I., Jeng, C-Y., and Reaven, G.M. (1987). HDL metabolism in diabetes. Diabetes/Met. Rev. 3, 653-668
38. 38 Howard, B.V. (1987). Lipoprotein metabolism in diabetes mellitus. J. Lipid. Res. 28, 613-628
39. 39 Tomkin, G.H. and Owens, D. (1994). Insulin and lipoprotein metabolism with special reference to the diabetic state. Diabetes Met. Rev. 10, 225-252
40. 40 McGarry, J., Wright, P.H., and Foster, D.W. (1975). Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon. J. Clini. Invest. 55, 1202-1209
41. 41 Nikkila, E.A. (1973). Triglyceride metabolism in diabetes mellitus. Progress Biochem. Pharma. 8, 271-299
42. 42 Janero, D.R., Siuta-Mangano, P., Miller, K.W., and Lane, M.D. (1984). Synthesis, processing, and secretion of hepatic very low density lipoprotein. J. Cell. Biochem. 24, 131-152
43. 43 Ginsberg, H.N., Le, N.A., and Gibson, J.C. (1985). Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss. J. Clini. Invest. 75, 614-623
44. 44 Lithell, H., Boberg, J., Hellsing, K., Lundgvist, G., and Vessby, B. (1978). Lipoprotein-lipase activity in human skeletal muscle and adipose tissue in the fasting and fed state. Atherosclerosis 30, 89-94
45. 45 Goldberg, A.P., Sherrard, D.J., Haas, L.B., and Brunzell, J.D. (1979). Effect of high carbohydrate feeding with dextrose or sucrose on adipose tissue lipoprotein lipase activity and plasma triglyceride levels in hemodialysis patients. Am. J. Clin. Nutr. 32, 1628-1635
46. 46 Nilsson-Ehle, P., Carlstrom, S., and Belfrage, P. (1975). Rapid effects of lipoprotein lipase activity in adipose tissue of humans after carbohydrate and lipid intake. Time course and relation to plasma glycerol, triglyceride and insulin levels. Scand. J. Clin. Lab. Invest. 35, 373-378
47. 47 Taskinen, M-R. and Nikkila, E.A. (1981). Lipoprotein lipase of adipose tissue and skeletal muscle in human obesity: Response to glucose and to semistarvation. Metabolism 30, 810-817
48. 48 Sadur, G.N. and Eckel, R.H. (1982). Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique. J. Clin. Invest. 69, 1119-1125
49. 49 Yki-Jarvinen, H., Taskinen, M-R., Koivisto, V.A., and Nikkila, E.A. (1984). Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man. Diabetologia 22, 364-369
50. 50 Arner, P., Bolinder, J., Engfeldt, P., and Lithell, H. (1983). The relationship between the basal lipolytic and lipoprotein lipase activities in human adipose tissue. Int. J. Obes. 7, 167-172
51. 51 Vessby, B., Selinus, I., and Lithell, H. (1985). Serum lipoprotein and lipoprotein lipase in overweight, Type II diabetics during and after supplemented fasting. Arteriosclerosis 5, 93-100
52. 52 Garfinkel, A.S., Nilsson-Ehle, P., and Schotz, M.C. (1976). Regulation of lipoprotein lipase induction by insulin. Biochem. Biophys. Acta 424, 264-273
53. 53 Cryer, A., Riley, S.E., Williams, E.R., and Robinson, D.S. (1976). Effect of nutritional status on rat adipose tissue, muscle and post-heparin plasma clearing factor lipase activity: Their relationship to triglyceride fatty acid uptake by fat-cells and to plasma insulin concentrations. Clin. Sci. Mol. Med. 50, 213-221
54. 54 Eckel, R.H., Prajad, J.E., Kern, P.A., and Marshall, S. (1984). Insulin regulation of lipoprotein lipase in altered isolated rat adipocytes. Endocrinology 114, 1665-1671
55. 55 Vydelingum, N., Drake, R.L., Etienne, J., and Kissebah, A.H. (1983). Insulin regulation of fat cell ribosomes, protein synthesis, and lipoprotein lipase. Am. J. Physiol. 245, E121-E131
56. 56 Awald, P.D., Gordon, D.F., Wood, W.M., Rule, D.C., Gutierrez-Hartman, A., and Eckel, W.R. (1988). Insulin-mediated increase in lipoprotein lipase specific mRNA precede increases in lipoprotein lipase activity in cultured rat adipocytes. Clin. Res. 36, 477a
57. 57 Ong, J.M., Kirchgessner, T.G., Schotz, M.C., and Kern, P.A. (1988). Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocytes. J. Biol. Chem. 263, 12933-12938
58. 58 Nikkila, E.A., Taskinen, M-R., Rehunen, S., and Harkonen, M. (1978). Lipoprotein lipase activity in adipose tissue and skeletal muscle in runners: relation to serum lipoproteins. Metabolism 27, 1661-1671
59. 59 Albrink, M.J. (1974). Dietary and drug treatment of hyperlipidemia in diabetes. Diabetes 23, 913-918
60. 60 Barrett-Connor, E., Grundy, S.M., and Holdbrook, M.J. (1982). Plasma lipids and diabetes mellitus in an adult community. Am. J. Epide. 115, 657-663
61. 61 Beach, K.W., Brunzell, J.D., Conquest, L.L., and Strandness, D.E. (1979). The correlation of arteriosclerosis obliterans with lipoproteins in insulin-dependent and non-insulin-dependent diabetics. Diabetes 28, 836-840
62. 62 Bierman, E.L., Amaral, J.A., and Belknap, B.H. (1966). Hyperlipemia and diabetes mellitus. Diabetes 15, 675-679
63. 63 Biesbroeck, R.C., Albers, J.J., Wahl, P.W., Weinberg, C.R., Bassett, M.L., and Bierman, E.L. (1982). Abnormal composition of high density lipoproteins in non-insulin-dependent diabetics. Diabetes 31, 126-131
64. 4 Briones, E.R., Mao, S.J., Palumbo, P.J., O'Fallen, W.M., Chenoweth, W., and Kottke, B.A. (1984). Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics. Metabolism 33, 42-49
65. 65 Howard, B.V., Knowler, W.C., Vasquez, B., Kennedy, A.L., Pettitt, D.J., and Bennett, P.H. (1984). Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Comparison of diabetics and nondiabetics. Arteriosclerosis 4, 462-471
66. 66 Kannel, W.B., Gordon, T., and Castelli, W.P. (1979). Obesity, lipids, and glucose intolerance. The Framingham Study. Am. J. Clini. Nutri. 32, 1238-1245
67. 67 Laakso, M., Voutilainen, E., Sarlund, H., Aro, A., Pyorala, K., and Penttila, I. (1985). Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics. Atherosclerosis 56, 271-281
68. 68 Lisch, H.J. and Sailer, S. (1981). Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics. Diabetologia 20, 118-122
69. 69 Mancini, M., Rivellese, A., Rubba, P., and Riccardi, G. (1980). Plasma lipoproteins in maturity onset diabetes. Nutri. and Metab. 24, 65-73
70. 70 Maruhama, Y., Abe, R., Okuguchi, F., and Ohneda, A. (1977). Dietary intake and hyperlipidemia in controlled diabetic outpatients. Diabetes 26, 94-99
71. 71 Mattock, M.B., Fuller, J.H., Maude, P.S., and Keen, H. (1979). Lipoproteins and plasma cholesterol esterification in normal and diabetic subjects. Atherosclerosis 34, 437-449
72. 72 Paisey, R., Elkeles, R.S., Hambley, J., and Magill, P. (1978). The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Diabetologia 15, 81-85
73. 73 Simpson, R.W., Mann, J.I., Hockaday, T.D., Hockaday, J.M., Turner, R.C., and Jelfs, R. (1979). Lipid abnormalities in untreated maturity-onset diabetics and the effects of treatment. Diabetologia 16, 101-106
74. 74 Taskinen, M.R., Nikkila, E.A., Kuusi, T., and Harmo, K. (1982). Lipoprotein lipase activity and serum lipoproteins in untreated type II (insulin-independent) diabetes associated with obesity. Diabetologia 22, 46-50
75. 75 Walden, C.E., Knopp, R.H., Wahl, P.W., Beach, K.W., and Strandness, E., Jr. (1984). Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N. Eng. J. Med. 311, 953-959
76. 76 West, K.M., Ahuja, M.M., Bennett, P.H., Czyzyk, A., De Acosta, O.M., Fuller, J.H., Grab, B., Grabauskas, V., Jarrett, R.J., and Kosaka, K. (1983). The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 6, 361-369
77. 77 Abrams, J.J., Ginsberg, H., and Grundy, S.M. (1982). Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus. Diabetes 31, 903-910
78. 78 Dunn, F.L., Raskin, P., Bilheimer, D.W., and Grundy, S.M. (1984). The effect of diabetic control on very-low-density lipoprotein-triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia. Metabolism 33, 117-123
79. 79 Ginsberg, H. and Grundy, S.M. (1982). Very low density lipoprotein metabolism in non-ketotic diabetes mellitus: effect of dietary restriction. Diabetologia 23, 421-425
80. 80 Kissebah, A.H., Adams, P.W., and Wynn, V. (1974). Interrelationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (phenformin). Diabetologia 10, 119-130
81. 81 Kissebah, A.H., Alfarsi, S., Evans, D.J., and Adams, P.W. (1982). Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus. Diabetes 31, 217-225
82. 82 Nikkila, E.A. and Kekki, M. (1973). Plasma triglyceride transport kinetics in diabetes mellitus. Metabolism 22, 1-22
83. 83 Sigurdsson, G., Nicoll, A., and Lewis, B. (1976). Metabolism of very low density lipoproteins in hyperlipidaemia: studies of apolipoprotein B kinetics in man. Eur. J. Clini. Inves. 6, 167-177
84. 84 Howard, B.V., Reitman, J.S., Vasquez, B., and Zech, L. (1983). Very-low-density lipoprotein triglyceride metabolism in noninsulin-dependent diabetes mellitus. Relationship to plasma insulin and free fatty acids. Diabetes 32, 271-276
85. 85 Howard, B.V., Abbott, W.G., Beltz, W.F., Harper, I.T., Fields, R.M., Grundy, S.M., and Taskinen, M.R. (1987). Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism 36, 870-877
86. 86 Taskinen, M.R., Beltz, W.F., Harper, I., Fields, R.M., Schonfeld, G., Grundy, S.M., and Howard, B.V. (1986). Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy. Diabetes 35, 1268-1277
87. 87 Bartlett, S.M. and Gibbons, G.F. (1988). Short and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin. Biochem. J. 249, 37-43
88. 88 Durrington, P.N., Newton, R.S., Weinstein, D.B., and Steinberg, D. (1982). Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J. Clin. Invest. 70, 63-73
89. 89 Mangiapane, E.H. and Brindley, D.N. (1986). Effects of dexamethasone and insulin on the synthesis of triacylglycerols and phosphatidylcholine and the secretion of very-low-density lipoproteins and lysophosphatidylcholine by monolayer cultures of rat hepatocytes. Biochem. J. 233, 151-160
90. 90 Patsch, W., Franz, S., and Schonfeld, G. (1983). Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J. Clin. Invest. 71, 1161-1174
91. 91 Pullinger, C.R. and Gibbons, G.F. (1985). Effects of hormones and pyruvate on the rates of secretion of very-low-density lipoprotein triacylglycerol and cholesterol by rat hepatocytes. Biochim. Biophys. Acta 833, 44-51
92. 92 Sparks, C.E., Sparks, J.D., Bolognino, M., Salhanick, A., Strumph, P.S., and Amatruda, J.M. (1986). Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes. Metabolism 35, 1128-1136
93. 93 Sparks, J.D. and Sparks, C.E. (1990). Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J. Biol. Chem. 265, 8854-8862
94. 94 Bjornsson, O.G., Duerden, J.M., Bartlett, S.M., Sparks, J.D., Sparks, C.E., and Gibbons, G.F. (1992). The role of pancreatic hormones in the regulation of lipid storage, oxidation and secretion in primary cultures of rat hepatocytes. Short and long-term effect. Biochem. J. 281, 381-386
95. 95 Dashti, N., Williams, D.L., and Alaupovic, P. (1989). Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J. Lipid Res. 30, 1365-1373
96. 96 Duerden, J.M., Bartlett, S.M., and Gibbons, G.F. (1989). Regulation of very-low-density-lipoprotein lipid secretion in hepatocyte cultures derived from diabetic animals. Biochem. J. 262, 313-319
97. 97 Gibbons, G.F. (1990). Assembly and secretion of hepatic very-low-density lipoprotein. Biochemistry 268, 1-13
98. 98 Sparks, J.D. and Sparks, C.E. (1994). Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim. Biophys. Acta 1215, 9-32
99. 99 Barakat, H.A., McLendon, V.D., Carpenter, J.W., Marks, R.H.L., Legett, N., O'Brien, K., and Caro, J.F. (1991). Lipogenic potential of liver from morbidly obese patients with and without non-insulin-dependent diabetes. Metabolism 40, 280-285
100. 100 Caro, J.F., Dohm, L.G., Pories, W.J., and Sinha, M.K. (1986). Studies on the mechanism of insulin resistance in the liver from humans with Noninsulin-dependent Diabetes. J. Clin. Invest. 78, 249-258
101. 101 Eckel, R.H. (1987). Adipose tissue lipoprotein lipase. In Lipoprotein Lipase (J. Borensztajn, ed.), pp. 79-132, Evener Publishers, Inc., Chicago
102. 102 Eckel, R.H. (1989). Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N. Engl. J. Med. 320, 1060-1068
103. 103 Brunzell, J.D., Porte, D., and Bierman, E.L. (1975). Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes). Metabolism 24, 1123-1137
104. 104 Pfeifer, M.A., Brunzell, J.D., Best, J.D., Judzewitch, R.G., Halter, J.B., and Porte, D. Jr. (1983). The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia. Diabetes 32, 525-531
105. 105 Persson, B. (1973). Lipoprotein lipase activity of human adipose tissue in health and in some diseases with hyperlipidemia as a common feature. Acta. Med. Scand. 193, 457-462
106. 106 Taylor, K.G., Galton, D.J., and Holdsworth, G. (1979). Insulin-independent diabetes: a defect in the activity of lipoprotein lipase in adipose tissue. Diabetologia 16, 313-317
107. 107 Taskinen, M.R. (1987). Lipoprotein lipase in diabetes. Diabetes/ Met. Reviews 3, 551-570
108. 108 Raynolds, M.V., Awald, P.D., Gordon, D.F., Gutierrez-Hartmann, A., Rule, D.C., Wood, W.M., and Eckel, R.H. (1990). Lipoprotein lipase gene expression in rat adiopocytes is regulated by isoproterenol and insulin through different mechanisms. Mol. Endocrinol. 4, 1416-1422
109. 109 Brown, M.S. and Goldstein, J.L. (1986). A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47
110. 110 Cerami, A., Vlassara, H., and Brownlee, M. (1988). Role of advanced glycosylation products in the complication of diabetes. Diabetes Care 11, 73-79
111. 111 Hiramatsu, K., Bierman, E.L., and Chair, A. (1985). Metabolism of low density lipoproteins from patients with hypertriglyceridemia by cultured human skin fibroblasts. Diabetes 34, 8-14
112. 112 Steinbrecher, U.P. and Witztum, J.L. (1984). Glucosylation of low density lipoproteins to the extent comparable to that seen in diabetes slows their catabotism. Diabetes 33, 130-134
113. 113 Curtis, L.K. and Witztum, J.L. (1985). Plasma apolipoproteins A-I, A-II, B, C-1 and E are glycolylated in hypertriglyceridemic diabetic subject. Diabetes 34, 452-461
114. 114 Kim, H-J. and Kurup, I.V. (1982). Nonenzymatic glycosylation of human low density lipoproteins. Evidence for in vivo and in vitro glycosylation. Metabolism 31, 348-353
115. 115 Jack, C.M., Sheridan, B., Kennedy, L., and Stout, R.W. (1988). Non-enzymatic glycosylation of low density lipoprotein. Results of an affinity chromatography method. Diabetologia 31, 126-127
116. 116 Barakat, H.A., Carpenter, J.W., McLender, V.D., Khazame, P., Legget, N., Heath, J., and Marks, R. (1990). Influences of obesity, impaired glucose tolerance and NIDDM on LDL structure and composition: Possible link between hyperinsulinemia and atherosclerosis. Diabetes 39, 1527-1533
117. 117 Stewart, M.W., Laber, M.F., Dyer, R.G., Game, F., Mitcheson, J., Winocerer, P.H., and Alberti, K.G.M.M. (1993). Lipoprotein compositional abnormalities and insulin resistance with type II diabetic patients with mild upper lipidemia. Arterioscler. Thromb. 13, 1046-1052
118. 118 Peeples, L.H., Carpenter, J.W., Israel, R.G., and Barakat, H.A. (1989). Alterations in low-density lipoproteins in subject with abdominal adiposity. Metabolism 38, 1029-1036
119. 119 Vague, J. (1956). The degree of masculine differentiation of obesities: A factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am. J. Clin. Nutr. 4, 20-34
120. 120 Krotkiewski, M., Bjrontorp, P., Sjostrom, L., and Smith, U. (1983). Impact of obesity on metabolism in men and women: Importance of regional adipose tissue distribution. J. Clin. Invest. 72, 1150-1162
121. 121 Evans, D.J., Murray, R., and Kissebah, A.H. (1984). Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography. J. Clin. Invest. 74, 1515-1525
122. 122 Evans, D., Hoffman, R., Kalkhoff, R., and Kissebah, A. (1983). Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J. Clin. Endocrin. Metab. 57, 304-310
123. 123 Evans, D., Hoffman, R., Kalkhoff, R., and Kissebah, A. (1984). Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenapausal women. Metabolism 33, 68-75
124. 124 Kalkhoff, R.K., Hartz, A.H., Rupley, D., Kissebah, A., and Kelber, S. (1983). Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. J. Lab. Clin. Med. 102, 621-627
125. 125 Kuusi, T., Ehnholm, C., Viikari, J., Harkonen, R., Vartiainen, E., Puska, P., and Taskinen, M-R. (1989). Post heparin plasma lipoprotein and hepatic lipase are determinants of hypo and hyperalphalipoproteinemia. J. Lipid Res. 30, 1117-1126
126. 126 Larsson, B., Svardsudd, K., Welin, L., Wilhelmsen, L., Bjorntorp, P., and Tibblin, G. (1984). Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913. Bri. Med. J. 288, 1401-1404
127. 127 Larsson, B. (1991). Obesity, fat distribution and cardiovascular disease. Int. J. Obes. 15, 53-57
128. 128 Pories, W.J., Swanson, M.S., MacDonald, K.G., Long, S.B., Morris, P.G., Brown, B.M., Barakat, H.A., deRamon, R.A., Israel, G., Dolezal, J.M., and Dohm, L. (1995). Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann. Surg. 222, 339-352
129. 129 Sells, T. and Barakat, H. (1994). Retardation of proliferation of U937 cells by low-density lipoproteins from patients with noninsulin-dependent diabetes mellitus. Med. Sci. Res. 22, 5-6
130. 130 Galeano, N.F., Milne, R., Marcel, Y.L., Walsh, M.T., Levy, E., Ngu'yen, T.D., Gleeson, A., Arad, Y., Witte, L., Al-Haideri, M., Rumsey, S.C., and Deckelbaum, R.J. (1994). Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J. Biol. Chem. 269, 511-519
131. 131 Eisenberg, S. (1984). High density lipoprotein metabolism. J. Lipid Res. 25, 1017-1058
132. 132 Tall, A. and Small, D. (1987). Plasma high density lipoproteins. N. Engl. J. Med. 299, 1232-1236
133. 133 Tall, A. (1990). Plasma high density lipoproteins: metabolism and relationship to atherogenesis. J. Clin. Invest. 86, 379-384
134. 134 Chajek, T. and Eisenberg, S. (1978). Very low density lipoprotein metabolism of phospholipids, cholesterol and apolipoprotein C in isolated perfused rat heart. J. Clin. Invest. 61, 1654-1665
135. 135 Jonas, A. (1991). Lecithin-cholesterol acyl transferase in the metabolism of high density lipoproteins. Biochim. Biophys. Acta 1084, 205-220
136. 136 Uusitupa, M., Siitonen, O., Voutilainen, E., Aro, A., Hersio, K., Pyorala, K., Penttila, I., and Ehnholm, C. (1986). Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (Type II) diabetic patients with special reference to factors influencing HDL-cholesterol and triglyceride levels. Diabetes Care 9, 17-22
137. 137 Pan, X.R., Walden, C.E., Warnick, G.R., Hu, S.X., Albers, J.J., Cheung, M., and Bierman, E.L. (1986). Comparison of plasma lipoproteins and apoproteins in Chinese and American non-insulin-dependent diabetic subjects and controls. Diabetes Care 9, 395-400
138. 138 Jiao, S., Kameda, K., Matsuzawa, Y., Kubo, M., Nonaka, K., and Tarui, S. (1986). Influence of endogenous hyperinsulinemia on high density lipoprotein2 level in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance. Atherosclerosis 60, 279-286
139. 139 Gordon, T., Castelli, W.P., Hjortland, M.C., Kannel, W.B., and Dawber, T.R. (1977). Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. Ann. Intern. Med. 87, 393-397
140. 140 Kennedy, A.L., Lappin, T.R.J., Lavery, T.D., Hadden, D.R., Weaver, J.A., and Montgomery, D.A. (1978). Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control. Br. Med. J. 2, 1191-1194
141. 141 Barrett-Conner, E., Wiztum, J., and Holdbrook, M. (1983). A community study of high density lipoproteins in adult noninsulin-dependent diabetes. Am. J. Epidemiol. 117, 186-192
142. 142 Laakso, M., Voutilainen, E., Sarlund, H., Aro, A., Pyorala, K., and Penttila, I. (1985). Inverse relationship of serum HDL and HDL2 cholesterol to C-peptide level in middle-aged insulin-treated diabetes. Metabolism 34, 715-720
143. 143 Hornick, C.A. and Fellmeth, B.D. (1981). High density lipoprotein cholesterol, insulin and obesity in Samoans. Atherosclerosis 39, 321-328
144. 144 Stalder, M., Pometta, D., and Suenram, A. (1981). Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy man. Diabetologia 21, 544-548
145. 145 Orchard, T.J., Becker, D.J., Bates, M., Kuller, L.H., and Drash, A.L. (1983). Plasma insulin and lipoprotein concentrations - an atherogenic association? Am. J. Epidemiol. 118, 326-337
146. 146 Golay, A., Zech, L., Shi, M-Z., Chiou, Y-A.M., Reaven, G.M., and Chen, Y-D.I. (1987). High density lipoprotein (HDL) metabolism in non-insulin dependent diabetes mellitus: Measurement of HDL turnover using tritiated HDL. J. Clin. Endocrinol. Metab. 65, 512-518
147. 147 Barakat, H.A., McLendon, V.D., Marks, R., Pories, W., Heath, J., and Carpenter, J.W. (1992). Influence of morbid obesity and noninsulin-dependent diabetes mellitus on high-density lipoprotein composition and subpopulation distribution. Metabolism 41, 37-41
148. 148 Nikkila, E.A., Huttunen, J.K., and Ehnholm, C. (1977). Post heparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Diabetes 26, 11-21
149. 149 Baynes, C., Henderson, A.D., Anyaoku, V., Richmond, W., Hughes, C.L., Johnston, D.G., and Elkeles, R.S. (1991). The role of insulin insensitivity and hepatic lipase in the dyslipidemia of type 2 diabetes. Diabetic Med. 8, 560-566
150. 150 Zambon, A., Austin, M.A., Brown, B.G., Hakanson, J.E., and Brunzell, J.D. (1993). Effects of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterio. Thromb. 13, 147-153
151. 151 Auwerx, J.H., Marzetta, C.A., Hokanson, J.E., and Brunzell, J.D. (1989). Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis 9, 319-325
152. 152 Tan, K.C.B., Cooper, M.B., Ling, K.L.E., Griffin, B.A., Freeman, D.J., Packard, C.J., Shepherd, J., Hales, C.N., and Betteridge, D.J. (1995). Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: The involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 113, 273-287
153. 153 al-Muhtaseb, N., al-yuosuf, A.R., and Bajaj, J.S. (1991). Plasma lipoproteins & apolipoproteins in insulin-dependent & young non insulin-dependent arab women. Acta Diabetologica Latina 28, 61-69
154. 154 Fielding, C., Reaven, G.M., and Fielding, P.E. (1982). Human noninsulin-dependent diabetes: Identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E. Proc. Natl. Acad. Sci. USA 79, 6365-6369
155. 155 Akanji, A.O. and Agbedana, E.O. (1995). Glycaemia and body mass as determinants of plasma lecithin: Cholesterol acyltransferase activity in Nigerian patients with noninsulin-dependent diabetes mellitus. Clin. Chem. Acta 228, 35-42
156. 156 Cavallero, E., Brites, F., Delfry, B., Nicolaieew, N., Decossin, C., De Geitere, C., Fruchart, J.C., Wikinski, R., Jacotot, B., and Castro, G. (1995). Abnormal reverse cholesterol transport in controlled type II diabetic patients - Studies on fasting and postprandial LpA-I particles. Arterio. Thromb. Vasc. Biol. 15, 2130-2135
157. 157 Tollefson, J.H. and Albers, J.J. (1986). Isolation, characterization, and assay of plasma lipid transfer proteins. Meth. Enzymol. 129, 797-816
158. 158 Hesler, C., Swenson, T., and Tall, A.R. (1987). Purification and characterization of human plasma cholesteryl ester transfer protein. J. Biol. Chem. 262, 2275-2282
159. 159 Drayna, D., Jarnagin, A.S., McLean, J., Henzel, W., Kohr, W., Fielding, C., and Lawn, R. (1987). Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 327, 632-634
160. 160 Agellon, L.B., Quinet, E.M., Gillette, T.M., Drayana, D.T., Brown, M.L., and Tall, A.R. (1990). Organization of the human cholesteryl ester transfer protein gene. Biochemistry 29, 1372-1376
161. 161 Tall, A.R. (1993). Plasma cholesteryl ester transfer protein. J. Lipid Res. 34, 1255-1274
162. 162 Lagrost, L. (1994). Regulation of cholesteryl ester transfer protein (CETP) activity: Review of in vitro and in vivo studies. Biochim. Biophys. Acta 1215, 209-236
163. 163 Inazu, A., Brown, M.L., Hesler, C.B., Agellon, L.B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., and Tall, A.R. (1990). Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N. Engl. J. Med. 323, 1234-1238
164. 164 Takahashi, K., Jiang, X.C., Sakai, N., Yamashita, S., Hirano, K., Bujo, H., Yamazaki, H., Kusunoki, J., Miura, T., Kussie, P., Matsuzawa, Y., Saito, Y., and Tall, A. (1993). A missing mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J. Clin. Invest. 92, 2060-2064.
165. 165 Inazu, A., Jiang, X.C., Haraki, T., Yagi, K., Kamon, N., Koizumi, J., Mabuchi, H., Takeda, R., Takata, K., Moriyama, Y., Doi, M., and Tall, A. (1994). Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J. Clin. Invest. 94, 1872-1882
166. 166 Son, Y.S.C. and Zilversmit, D.B. (1986). Increased lipid transfer activities in hyperlipidemic rabbit plasma. Arteriosclerosis 6, 345-351
167. 167 Quig, D.W., Arbeeny, C.M., and Zilversmit, D.B. (1991). Effects of hyperlipidemias in hamsters on lipid transfer protein activity and unidirectional cholesteryl ester transfer in plasma. Biochim. Biophys. Acta 1083, 257-264
168. 168 Quig, D.W. and Zilversmit, D.B. (1988). Plasma lipid transfer activity in rabbits: effects of dietary hyperlipidemias. Atherosclerosis 70, 263-271
169. 169 Tall, A., Sammett, D., and Granot, E. (1986). Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. Amer. Soc. Clin. Invest. 77, 1163-1172
170. 170 Tall, A., Granot, E., Brocia, R., Tabas, I., Hesler, C., Williams, K., and Denke, M. (1987). Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J. Clin. Invest. 79, 1217-1225
171. 171 Jiang, X.C., Agellon, L.B., Walsh, A., Breslow, J.L., and Tall, A. (1992). Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences. J. Clin. Invest. 90, 1290-1295
172. 172 McPherson, R., Hogue, M., Milne, R.W., Tall, A.R., and Marcel, Y.L. (1991). Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoproteins composition. Arterio. Thromb. 11, 476-481
173. 173 Quinet, E.M., Huerta, P., Nancoo, D., Tall, A.R., Marcel, Y.L., and McPherson, R. (1993). Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: Cholesterol and species dependence. J. Lipid Res. 34, 845-852
174. 174 Homma, Y., Ozawa, H., Kobayashi, T., Yamaguchi, H., Sakane, H., and Nakamura, H. (1995). Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia. Atherosclerosis 114, 223-234
175. 175 Bagdade, J.D., Ritter, M.C., and Subbaiah, P.V. (1991). Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 21, 161-167
176. 176 Fielding, J.C., Reaven, G.M., Liu, G., and Fielding, P.E. (1984). Increased free cholesterol in plasma low and very low density lipoproteins in noninsulin-dependent diabetes mellitus: Its role in the inhibition of cholesteryl ester transfer. Proc. Natl. Acad. Sci. USA 81, 2512-2516
177. 177 Kahri, J., Groop, P.H., Elliott, T., Viberti, G., and Taskinen, M.-R. (1994). Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy. Diabetes Care 17, 412-419
178. 178 Vadlamudi, S., Maclean, P., Cayton, R., Pories, W., Macdonald, K., Swanson, M., Morris, P., Long, S., and Barakat, H. (1996). Cholesterol Ester Transfer Protein Regulation in NIDDM. Diabetes 45, 91A
179. 179 Bagdade, J.D., Lane, J.T., Subbiah, P.V., and Ritter, M.C. (1993). Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus. Atherosclerosis 104, 69-77
180. 180 Jiang, X.C., Moulin, P., Quinet, E., Goldberg, I.J., Yacoub, L.K., Agellon, L.B., Compton, D., Schnitzer-Polokoff, R., and Tall, A.R. (1991). Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J. Biol. Chem. 266, 4631-4639
181. 181 Shen, G.X. and Angel, A. (1995). Regulation of cholesteryl ester transfer activity in adipose tissue: Comparison between hamster and rat species. Am. J. Physiol. Endocrinol. Metab. 269, E99-E107
182. 182 Sutherland, W.H.F., Walker, R.J., Lewis-Barned, N.J., Pratt, H., and Tillman, H.C. (1994). The effect of acute hyperinsulinemia on plasma cholesteryl ester transfer protein activity in patients with non-insulin dependent diabetes mellitus and healthy subjects. Metabolism 43, 1362-1366